Please Wait.....
Report
Nucleic Acid Sample Preparation Market- Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028 Segmented By Product (Consumables, Systems and Accessories & Components), By Technology (Spin-Column Based Technology, Magnetic-Bead Based Technology and Others), By Therapeutic Area (Oncology, Infectious Disease, Human Genetics/Population Genetics, Others), By Application (Genomics, Proteomics and Others), By End Users (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories and Other) ,By Region and Competition
Market Report I 2023-07-01 I 116 Pages I TechSci Research
Nucleic Acid Sample Preparation Market is expected to register an impressive CAGR during the forecast period of 2024-2028. This can be attributed to factors such as the growing usage of nucleic acid molecules in various therapeutic areas.
Moreover, other factors, such as growing advancement in nucleic acid extraction and isolation techniques and growing demand for downstream applications such as Next Generation Sequencing (NGS), targeted sequencing, etc., drive the growth of the Nucleic Acid Sample Preparation market.
Growing Research & Development in Life Sciences
Increasing investment by the government, academics & institutions, etc., to expand research in life science is expected to drive the market demand for the Nucleic Acid Sample Preparation market. For instance, in February 2022, Brightlamp Inc. and Purdue-affiliated Amplified Sciences LLC received a grant of approximately US$ 250,000 each from the Purdue Foundry Investment Fund for R&D to bring advancement in life sciences. The Amplifies Sciences is researching advancing technology for pre-diagnosis of cancer and other diseases. Similarly, Brightlamp is a company that utilizes machine learning and computer vision to enhance and improve healthcare.
Growing Usage of Nucleic Acid in Therapeutic Areas
With the growing demand for disease diagnosis on time and the need for diagnostic information in several patient treatments, distinct molecular procedures are developed and thus are increasing the nucleic acid sample extraction to follow the diagnosis procedures and is anticipated to offer lucrative demand to the nucleic acid sample preparation market. Moreover, the growing prevalence of chronic diseases such as cancer is increasing the need for diagnosis at the molecular level, and thus increase in demand for nucleic acid sample extraction and preparation is driving the market growth during the forecast period. Moreover, sample preparation is an essential application in precision medicine on account of its safety assurance level and successful use of tailored therapies.
Growing Demand for Nucleic Acid Extraction Systems
Nucleic acid isolation /extraction is the most basic step involved in molecular diagnosis or any molecular laboratory research and is expanding with the availability of a distinct range of equipment and methods used for the extraction of samples. The availability of automated nucleic acid extraction systems is bolstering the market growth for the nucleic acid sample preparation market. Moreover, increased automation has leads to running multiple samples at the same time with minimum error ratio and also can extract nucleic acid from distinct samples, such as serum and tissue, cell culture and thus is expected to accelerate the Nucleic Acid Sample Preparation Market. For instance, in February 2020, the market player Covaris Inc. introduced two new kits for viral RNA extraction with throat or nasal swab collection devices, which include the truXTRAC-PCR Direct viral RNA Extraction kit and truXTRAC Viral RNA Extraction kit.
Growing demand for Next generation Sequencing (Downstream applications)
The increased demand for Next-generation Sequencing (NGS) in disease is propelling the demand for the Nucleic Acid Sample Preparation market. The gene or targeted sequence carries a gene or interest or a disease carrier and thus can be identified and used in disease diagnosing. Additionally, targeted sequencing allows researchers to target particular genes of interest, coding areas, and even chromosomal segments, making it a useful technique for sequencing in order to collect accurate, quick, and precise data. The availability of kits and developed reagents for sequencing procedures is attributed to support the market growth and bolster the Nucleic Acid Sample Preparation market during the forecast period.
Recent Developments
Key market players are introducing their new products and expanding their product portfolio. For instance, in February 2020, Miroculus Inc. introduced its Miro Canvas -a new system that can automate, simplify and miniaturize complex protocols like nest generation sequencing library preparation.
Market Segmentation
The Nucleic Acid Sample Preparation Market is segmented based on product, technology, therapeutic area, application, end users, and region. Based on product, the market is further segmented into consumables, systems, and accessories & components. Based on technology, the market is further segmented into spin-column-based technology, magnetic-bead-based technology, and others. Based on Therapeutic Area, the market is segmented into oncology, infectious disease, human genetics/population genetics, and others. Based on application, the market is further segmented into genomics, proteomics, and others. Based on end users, the market is further segmented into end users (academic and research institutions, pharmaceutical and biotechnology companies, clinical and diagnostic laboratories, and others. Based on the region, the market is further segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Market Players
BGI Group (MGI Tech Co., Ltd.), F. Hoffmann-La Roche Ltd, Danaher. (Beckman Coulter, Inc.), Eppendorf SE, Bioneer Corporation, Endress+Hauser Group Services AG (Analytik Jena GmbH), Merck KGaA, Norgen Biotek Corp, Aurora Biomed Inc., Agilent Technologies, Inc., are some of the major players operating in the global nucleic acid sample preparation Market.
Report Scope:
In this report, Nucleic Acid Sample Preparation Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
- Nucleic Acid Sample Preparation, By Product:
o Consumables
o Systems
o Accessories & Components
- Nucleic Acid Sample Preparation, By Technology:
o Spin-Column-Based Technology
o Magnetic-Bead Based Technology
o Others
- Nucleic Acid Sample Preparation, By Therapeutic Area:
o Oncology
o Infectious Disease
o Human Genetics/Population Genetics
o Others
- Nucleic Acid Sample Preparation, By Application:
o Genomics
o Proteomics
o Others
- Nucleic Acid Sample Preparation, By End Users:
o Academic and Research Institutions
o Pharmaceutical
o Biotechnology Companies
o Clinical and Diagnostic Laboratories
o Other
- Nucleic Acid Sample Preparation, By Region:
o North America
- United States
- Canada
- Mexico
o Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
o Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
o Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
o South America
- Brazil
- Argentina
- Colombia
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Nucleic Acid Sample Preparation market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered.
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Clinical Trial Analysis
4.1. Ongoing Clinical Trials
4.2. Completed Clinical Trials
4.3. Terminated Clinical Trials
4.4. Breakdown of Pipeline, By Development Phase
4.5. Breakdown of Pipeline, By Status
4.6. Breakdown of Pipeline, By Study Type
4.7. Breakdown of Pipeline, By Region
4.8. Clinical Trials Heat Map
5. Voice of Customer
6. Nucleic Acid Sample Preparation Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Consumables, Systems and Accessories & Components)
6.2.2. By Technology (Spin-Column Based Technology, Magnetic-Bead Based Technology and Others)
6.2.3. By Therapeutic Area (Oncology, Infectious Disease, Human Genetics/Population Genetics, Others)
6.2.4. By Application (Genomics, Proteomics and Others)
6.2.5. By End Users (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories and Other)
6.2.6. By Company (2022)
6.2.7. By Region
6.3. Product Market Map
7. Asia-Pacific Nucleic Acid Sample Preparation Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. Product
7.2.2. Technology
7.2.3. Therapeutic Area
7.2.4. Application
7.2.5. End Users
7.2.6. By Country
7.3. Asia-Pacific: Country Analysis
7.3.1. China Nucleic Acid Sample Preparation Market Outlook.
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. Product
7.3.1.2.2. Technology
7.3.1.2.3. Therapeutic Area
7.3.1.2.4. Application
7.3.1.2.5. End Users
7.3.2. India Nucleic Acid Sample Preparation Market Outlook.
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. Product
7.3.2.2.2. Technology
7.3.2.2.3. Therapeutic Area
7.3.2.2.4. Application
7.3.2.2.5. End Users
7.3.3. South Korea Nucleic Acid Sample Preparation Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. Product
7.3.3.2.2. Technology
7.3.3.2.3. Therapeutic Area
7.3.3.2.4. Application
7.3.3.2.5. End Users
7.3.4. Japan Nucleic Acid Sample Preparation Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. Product
7.3.4.2.2. Technology
7.3.4.2.3. Therapeutic Area
7.3.4.2.4. Application
7.3.4.2.5. End Users
7.3.5. Australia Nucleic Acid Sample Preparation Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. Product
7.3.5.2.2. Technology
7.3.5.2.3. Therapeutic Area
7.3.5.2.4. Application
7.3.5.2.5. End Users
8. Europe Nucleic Acid Sample Preparation Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. Product
8.2.2. Technology
8.2.3. Therapeutic Area
8.2.4. Application
8.2.5. End Users
8.2.6. By Country
8.3. Europe: Country Analysis
8.3.1. France Nucleic Acid Sample Preparation Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. Product
8.3.1.2.2. Technology
8.3.1.2.3. Therapeutic Area
8.3.1.2.4. Application
8.3.1.2.5. End Users
8.3.2. Germany Nucleic Acid Sample Preparation Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. Product
8.3.2.2.2. Technology
8.3.2.2.3. Therapeutic Area
8.3.2.2.4. Application
8.3.2.2.5. End Users
8.3.3. United Kingdom Nucleic Acid Sample Preparation Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. Product
8.3.3.2.2. Technology
8.3.3.2.3. Therapeutic Area
8.3.3.2.4. Application
8.3.3.2.5. End Users
8.3.4. Italy Nucleic Acid Sample Preparation Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. Product
8.3.4.2.2. Technology
8.3.4.2.3. Therapeutic Area
8.3.4.2.4. Application
8.3.4.2.5. End Users
8.3.5. Spain Nucleic Acid Sample Preparation Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. Product
8.3.5.2.2. Technology
8.3.5.2.3. Therapeutic Area
8.3.5.2.4. Application
8.3.5.2.5. End Users
9. North America Humic-based bio stimulants Market Outlook.
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. Product
9.2.2. Technology
9.2.3. Therapeutic Area
9.2.4. Application
9.2.5. End Users
9.2.6. By Country
9.3. North America: Country Analysis
9.3.1. United States Nucleic Acid Sample Preparation Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. Product
9.3.1.2.2. Technology
9.3.1.2.3. Therapeutic Area
9.3.1.2.4. Application
9.3.1.2.5. End Users
9.3.2. Mexico Nucleic Acid Sample Preparation Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. Product
9.3.2.2.2. Technology
9.3.2.2.3. Therapeutic Area
9.3.2.2.4. Application
9.3.2.2.5. End Users
9.3.3. Canada Nucleic Acid Sample Preparation Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. Product
9.3.3.2.2. Technology
9.3.3.2.3. Therapeutic Area
9.3.3.2.4. Application
9.3.3.2.5. End Users
10. South America Nucleic Acid Sample Preparation Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. Product
10.2.2. Technology
10.2.3. Therapeutic Area
10.2.4. Application
10.2.5. End Users
10.2.6. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Nucleic Acid Sample Preparation Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. Product
10.3.1.2.2. Technology
10.3.1.2.3. Therapeutic Area
10.3.1.2.4. Application
10.3.1.2.5. End Users
10.3.2. Argentina Nucleic Acid Sample Preparation Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. Product
10.3.2.2.2. Technology
10.3.2.2.3. Therapeutic Area
10.3.2.2.4. Application
10.3.2.2.5. End Users
10.3.3. Colombia Nucleic Acid Sample Preparation Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. Product
10.3.3.2.2. Technology
10.3.3.2.3. Therapeutic Area
10.3.3.2.4. Application
10.3.3.2.5. End Users
11. Middle East and Africa Nucleic Acid Sample Preparation Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. Product
11.2.2. Technology
11.2.3. Therapeutic Area
11.2.4. Application
11.2.5. End Users
11.2.6. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Nucleic Acid Sample Preparation Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. Product
11.3.1.2.2. Technology
11.3.1.2.3. Therapeutic Area
11.3.1.2.4. Application
11.3.1.2.5. End Users
11.3.2. Saudi Arabia Nucleic Acid Sample Preparation Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. Product
11.3.2.2.2. Technology
11.3.2.2.3. Therapeutic Area
11.3.2.2.4. Application
11.3.2.2.5. End Users
11.3.3. UAE Nucleic Acid Sample Preparation Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. Product
11.3.3.2.2. Technology
11.3.3.2.3. Therapeutic Area
11.3.3.2.4. Application
11.3.3.2.5. End Users
11.3.4. Kuwait Nucleic Acid Sample Preparation Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. Product
11.3.4.2.2. Technology
11.3.4.2.3. Therapeutic Area
11.3.4.2.4. Application
11.3.4.2.5. End Users
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
13.1. Recent Developments
13.2. Mergers & Acquisitions
13.3. Product Developments
14. Competitive Landscape
14.1. Business Overview
14.2. Company Snapshot
14.3. Products & Services
14.4. Financials (In case of listed companies)
14.5. Recent Developments
14.6. SWOT Analysis
14.6.1. BGI Group (MGI Tech Co., Ltd.)
14.6.2. F. Hoffmann-La Roche Ltd
14.6.3. Danaher. (Beckman Coulter, Inc.)
14.6.4. Eppendorf SE
14.6.5. Bioneer Corporation
14.6.6. Endress+Hauser Group Services AG (Analytik Jena GmbH)
14.6.7. Merck KGaA
14.6.8. Norgen Biotek Corp
14.6.9. Aurora Biomed Inc.
14.6.10. Agilent Technologies, Inc
15. Strategic Recommendations
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security